Scarica l'app Stockscreener
2.27
2.71%
0.06
Dopo l'orario di chiusura:
2.30
0.03
+1.32%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AYTU Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.21
Aprire:
$2.2
Volume 24 ore:
36,453
Relative Volume:
0.19
Capitalizzazione di mercato:
$20.38M
Reddito:
$66.38M
Utile/perdita netta:
$-14.18M
Rapporto P/E:
-0.8086
EPS:
-2.8074
Flusso di cassa netto:
$-5.17M
1 W Prestazione:
+0.00%
1M Prestazione:
+20.74%
6M Prestazione:
+68.15%
1 anno Prestazione:
+18.23%
Intervallo 1D:
$2.1801
$2.29
Intervallo di 1 settimana:
$2.15
$2.31
Portata 52W:
$0.95
$2.82
Aytu Biopharma Inc Stock (AYTU) Company Profile
Nome
Aytu Biopharma Inc
Settore
Telefono
(720) 437-6580
Indirizzo
7900 E. UNION AVENUE, DENVER
Confronta AYTU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.27 | 22.52M | 66.38M | -14.18M | -5.17M | -2.8074 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Iniziato | Lake Street | Buy |
| 2025-06-30 | Iniziato | Ascendiant Capital Markets | Buy |
| 2021-03-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-05-29 | Iniziato | H.C. Wainwright | Buy |
Aytu Biopharma Inc Borsa (AYTU) Ultime notizie
Real time social sentiment graph for Aytu BioPharma Inc.July 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com
How to escape a deep drawdown in Aytu BioPharma Inc.Weekly Profit Summary & Risk Managed Investment Entry Signals - newser.com
What MACD signals say about Aytu BioPharma Inc.July 2025 Breakouts & Reliable Trade Execution Plans - newser.com
Will Aytu BioPharma Inc. (AY20) stock profit from fiscal stimulus2025 Retail Activity & Daily Profit Focused Stock Screening - newser.com
Published on: 2025-10-31 04:46:09 - newser.com
Applying Elliott Wave Theory to Aytu BioPharma Inc.Trade Exit Summary & Weekly Breakout Watchlists - newser.com
Will Aytu BioPharma Inc. stock remain a Wall Street favoriteTrade Analysis Summary & AI Enhanced Market Trend Forecasts - newser.com
Will Aytu BioPharma Inc. stock see insider buyingEarnings Recap Summary & Daily Stock Momentum Reports - newser.com
Can Aytu BioPharma Inc. (AY20) stock withstand sector downturnsWeekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Understanding Aytu BioPharma Inc.’s price movementMarket Rally & Free Community Supported Trade Ideas - newser.com
Will Aytu BioPharma Inc. (AY20) stock keep high P E multiplesFed Meeting & Weekly High Return Stock Forecasts - newser.com
Relative strength of Aytu BioPharma Inc. in sector analysisMarket Risk Analysis & Growth Focused Entry Reports - newser.com
Will Aytu BioPharma Inc. stock attract more institutional investors2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com
There's No Escaping Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Muted Revenues Despite A 27% Share Price Rise - simplywall.st
How to interpret RSI for Aytu BioPharma Inc. stockWeekly Stock Analysis & Short-Term High Return Ideas - newser.com
Aytu’s EXXUA patent extended through 2030 for depression treatment By Investing.com - Investing.com Australia
Published on: 2025-10-29 04:11:29 - newser.com
Will Aytu BioPharma Inc. (AY20) stock announce a stock splitPortfolio Growth Summary & Advanced Swing Trade Entry Alerts - newser.com
Can Aytu BioPharma Inc. (AY20) stock deliver consistent EPS growth2025 Technical Overview & Stepwise Swing Trade Plans - newser.com
Published on: 2025-10-28 23:00:39 - newser.com
Aytu BioPharma (AYTU) Secures Patent Extension for EXXUA Till 20 - GuruFocus
Aytu’s EXXUA patent extended through 2030 for depression treatment - Investing.com
Aytu BioPharma Announces Patent Term Extension for EXXUA(TM) - ACCESS Newswire
Aytu BioPharma (NASDAQ: AYTU) Extends EXXUA Patent Protection Through 2030 - Stock Titan
Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Share Price Boosted 27% But Its Business Prospects Need A Lift Too - 富途牛牛
Does Aytu BioPharma Inc. qualify in momentum factor screeningTreasury Yields & Long-Term Growth Plans - newser.com
Published on: 2025-10-28 02:48:14 - newser.com
Is Aytu BioPharma Inc. stock a defensive play in 2025CPI Data & Low Risk High Win Rate Picks - Fundação Cultural do Pará
Aytu Biopharma Inc Azioni (AYTU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Aytu Biopharma Inc Azioni (AYTU) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Disbrow Joshua R. | Chief Executive Officer |
Jun 09 '25 |
Buy |
1.50 |
66,666 |
99,999 |
153,257 |
| Disbrow Joshua R. | Chief Executive Officer |
Feb 28 '25 |
Buy |
1.30 |
15,000 |
19,500 |
86,591 |
3.18%
1.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):